Androgen receptor-driven chromatin looping in prostate cancer

Trends Endocrinol Metab. 2011 Dec;22(12):474-80. doi: 10.1016/j.tem.2011.07.006. Epub 2011 Aug 31.

Abstract

The androgen receptor (AR) is important for prostate cancer development and progression. Genome-wide mapping of AR binding sites in prostate cancer has found that the majority of AR binding sites are located within non-promoter regions. These distal AR binding regions regulate AR target genes (e.g. UBE2C) involved in prostate cancer growth through chromatin looping. In addition to long-distance gene regulation, looping has been shown to induce spatial proximity of two genes otherwise located far away along the genomic sequence and the formation of double-strand DNA breaks, resulting in aberrant gene fusions (e.g. TMPRSS2-ERG) that also contribute to prostate tumorigenesis. Elucidating the mechanisms of AR-driven chromatin looping will increase our understanding of prostate carcinogenesis and may lead to the identification of new therapeutic targets.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Androgens / adverse effects
  • Androgens / metabolism*
  • Animals
  • Carcinogens / metabolism
  • Carcinogens / toxicity
  • Chromatin Assembly and Disassembly*
  • Gene Fusion / drug effects
  • Humans
  • Male
  • Molecular Targeted Therapy
  • Mutant Chimeric Proteins / genetics
  • Mutant Chimeric Proteins / metabolism
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Prostatic Neoplasms / chemically induced
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / metabolism*
  • Receptors, Androgen / metabolism*
  • Signal Transduction* / drug effects

Substances

  • Androgens
  • Carcinogens
  • Mutant Chimeric Proteins
  • Neoplasm Proteins
  • Receptors, Androgen